Tag: Injection reactions

Up to 20% of patients receiving certain injectable medications, like adalimumab, experience injection site reactions, including localized hardening. Understanding if and when an **injection site should be hard** is key to knowing if a reaction is normal or requires medical attention.

In clinical trials, a significant number of patients reported systemic injection-related reactions, most commonly within 24 hours of the first Kesimpta dose. This initial experience, alongside long-term side effects like increased vulnerability to infections, helps answer the crucial question: how does Kesimpta make you feel?

In clinical studies, the most common side effects reported with HAEGARDA were injection-site reactions, hypersensitivity, dizziness, and nasal symptoms. This medication, a C1 esterase inhibitor used for hereditary angioedema (HAE) prophylaxis, carries both mild and serious potential side effects that users should be aware of.